Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis

An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

NCT01286090 ·Status: TERMINATED ·Phase: PHASE4

A Scintigraphy Study in Adults With Diabetic Gastroparesis

NCT04208698 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis

NCT01557296 ·Status: COMPLETED ·Phase: PHASE2

Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.

NCT02225951 ·Status: TERMINATED ·Phase: NA

A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes

NCT00809705 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis

NCT00861809 ·Status: COMPLETED ·Phase: PHASE2

Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

NCT02289846 ·Status: COMPLETED ·Phase: PHASE2

A Study of CNSA-001 in Women With Diabetic Gastroparesis

NCT03712124 ·Status: COMPLETED ·Phase: PHASE2

Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes

NCT04449692 ·Status: COMPLETED ·Phase: PHASE2

Trial Investigating Efficacy of G-POEM

NCT05830994 ·Status: UNKNOWN ·Phase: NA

An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects

NCT02793154 ·Status: TERMINATED ·Phase: PHASE4

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

NCT00537719 ·Status: COMPLETED ·Phase: PHASE1

Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

NCT01176890 ·Status: UNKNOWN ·Phase: NA

Acupuncture for Diabetic Gastroparesis

NCT00470795 ·Status: SUSPENDED ·Phase: PHASE3

Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)

NCT06695962 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options

NCT02365740 ·Status: UNKNOWN ·Phase: NA

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

NCT00993720 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

NCT03442972 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

NCT04696159 ·Status: RECRUITING ·Phase: NA

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

NCT04118374 ·Status: COMPLETED ·Phase: NA

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

NCT05470504 ·Status: RECRUITING ·Phase: PHASE2

G-POEM for Glycemic Control in Diabetic Gastroparesis

NCT06965543 ·Status: NOT_YET_RECRUITING ·Phase: NA

Oral Propionate to Treat and Prevent Diabetes

NCT01692002 ·Status: TERMINATED ·Phase: NA

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

NCT02592421 ·Status: COMPLETED ·Phase: PHASE3